Citadel Advisors
LOAC

Citadel Advisors’s Longevity Acquisition Corporation Ordinary Shares LOAC Stock Holding History

Citadel Advisors’s Portfolio LOAC Stock Details LOAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,533
Closed -$135K – 11811
2020
Q3 		$135K Sell
12,533
-3,180
-20% -$34.1K ﹤0.01% 9078
2020
Q2 		$169K Sell
15,713
-2,237
-12% -$23.7K ﹤0.01% 8661
2020
Q1 		$189K Sell
17,950
-1,601
-8% -$16.8K ﹤0.01% 8068
2019
Q4 		$204K Buy
+19,551
New +$204K ﹤0.01% 8157

Other funds holding LOAC

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's LOAC Position: Q4 2020 in Review

Citadel Advisors sold out of Longevity Acquisition Corporation Ordinary Shares (LOAC) in Q4 2020, closing a stake of 12,533 shares — an estimated $135K sold.

Citadel Advisors first reported a position in LOAC in Q4 2019 and held it in 4 quarters. The position peaked at $204K in Q4 2019. 8 funds tracked by Wall St. Rank hold LOAC as of Q4 2020.

  • Citadel Advisors reported no remaining Longevity Acquisition Corporation Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • Citadel Advisors sold 12,533 Longevity Acquisition Corporation Ordinary Shares shares in Q4 2020, an estimated $135K.
  • Citadel Advisors first reported a position in Longevity Acquisition Corporation Ordinary Shares in Q4 2019 and held it in 4 quarters.
  • Citadel Advisors's Longevity Acquisition Corporation Ordinary Shares position peaked at $204K in Q4 2019.
  • 8 funds tracked by Wall St. Rank held Longevity Acquisition Corporation Ordinary Shares as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.